# FDA recall D-0296-2016

> **Blue Square Market, Inc.** · Class I · drug recall initiated 2015-08-06.

## Product

LiDa DAIDAIHUA (also packaged as LiDa DAIDAIHUAJIAONANG), capsules, packaged in 1.6oz box 30 capsules per box, Kunming Dali Industry & Trade Co., Ltd

## Reason for recall

Marketed Without An Approved NDA/ANDA: presence of undeclared Sibutramine and Phenolphthalein.

## Distribution

Nationwide

## Key facts

- **Recall number:** D-0296-2016
- **Recalling firm:** Blue Square Market, Inc.
- **Classification:** Class I
- **Product type:** drug
- **Status:** Terminated
- **Initiation date:** 2015-08-06
- **Report date:** 2015-11-25
- **Termination date:** 2018-10-18

- **Voluntary/Mandated:** Voluntary: Firm initiated
- **Location:** North Huntingdon, PA, United States

## Primary source

FDA Enforcement Reports: https://www.accessdata.fda.gov/scripts/ires/index.cfm?Product=D-0296-2016

## Citation

> AI Analytics. FDA recall D-0296-2016. Retrieved 2026-05-28 from https://api.ai-analytics.org/recall/D-0296-2016. Source: US FDA. Licensed CC0.

---

*[Dataset catalog](/datasets/) · [FDA recalls dataset](/datasets/fda-recalls) · CC0 1.0*